Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. It also engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Shenzhen, China.
Frequently asked questions
What sector does Kangmei Pharmaceutical Co Ltd (600518) operate in?
Kangmei Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Kangmei Pharmaceutical Co Ltd (600518) current stock price?
As of the latest data, Kangmei Pharmaceutical Co Ltd stock price is CN¥1.40, with a previous close of CN¥1.42. Kangmei Pharmaceutical Co Ltd lost -CN¥0.02 in the last trading session, representing a -1.41% loss.
What is Kangmei Pharmaceutical Co Ltd (600518) current market capitalization?
Kangmei Pharmaceutical Co Ltd market cap is approximately 19.36 billion.
Does Kangmei Pharmaceutical Co Ltd (600518) pay dividends?
No. Kangmei Pharmaceutical Co Ltd does not pay a dividend.
What is Kangmei Pharmaceutical Co Ltd (600518) beta (volatility) score?
Kangmei Pharmaceutical Co Ltd has a beta of 0.489, indicating lower volatility than the overall market.
